{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113762.1.4.1235.228",
  "meta" : {
    "versionId" : "6",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueString" : "B.well Connected Health Author"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2024-06-04"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2023-01-18"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.228",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113762.1.4.1235.228"
    }
  ],
  "version" : "20230118",
  "name" : "InfluenzaVaccineCN_HD_SNOMED",
  "title" : "Influenza Vaccine CN_HD_SNOMED",
  "status" : "active",
  "date" : "2023-01-18T01:03:05-05:00",
  "publisher" : "B.well Connected Health Steward",
  "description" : "b.well created value set by Sr. Clinical Business Analyst for Influenza Vaccine - Adult Care Need.",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: The intent of this value set is for the purpose of defining the clinical codes that constitute Influenza Vaccine - Adult Care Need for inclusion and utilization in patients/users connected heath.),(Data Element Scope: Influenza Vaccine - Adult Care Need for b.well.),(Inclusion Criteria: Codes that constitute the Flu Vaccine - Adult & Influenza Vaccine - Adult Care Need for b.well.),(Exclusion Criteria: N/A)",
  "compose" : {
    "include" : [
      {
        "system" : "http://snomed.info/sct",
        "concept" : [
          {
            "code" : "127787002",
            "display" : "Administration of vaccine product containing only Haemophilus influenzae type B antigen (procedure)"
          },
          {
            "code" : "16292241000119109",
            "display" : "Administration of booster dose of vaccine product containing only Haemophilus influenzae type B capsular polysaccharide polyribosylribitol phosphate conjugated to Clostridium tetani toxoid protein (procedure)"
          },
          {
            "code" : "170343007",
            "display" : "Administration of first dose of vaccine product containing only Haemophilus influenzae type B antigen (procedure)"
          },
          {
            "code" : "170344001",
            "display" : "Administration of second dose of vaccine product containing only Haemophilus influenzae type B antigen (procedure)"
          },
          {
            "code" : "170345000",
            "display" : "Administration of third dose of vaccine product containing only Haemophilus influenzae type B antigen (procedure)"
          },
          {
            "code" : "170346004",
            "display" : "Administration of booster dose of vaccine product containing only Haemophilus influenzae type B antigen (procedure)"
          },
          {
            "code" : "310306005",
            "display" : "Administration of first dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Human poliovirus antigens (procedure)"
          },
          {
            "code" : "310307001",
            "display" : "Administration of second dose of Vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Human poliovirus antigens (procedure)"
          },
          {
            "code" : "310308006",
            "display" : "Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Human poliovirus antigens (procedure)"
          },
          {
            "code" : "312869001",
            "display" : "Administration of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Human poliovirus antigens (procedure)"
          },
          {
            "code" : "312870000",
            "display" : "Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Human poliovirus antigens (procedure)"
          },
          {
            "code" : "346524008",
            "display" : "Influenza split virion vaccine (product)"
          },
          {
            "code" : "346525009",
            "display" : "Inactivated Influenza surface antigen sub-unit vaccine (product)"
          },
          {
            "code" : "348046004",
            "display" : "Influenza (split virion) vaccine injection suspension 0.5mL prefilled syringe (product)"
          },
          {
            "code" : "348047008",
            "display" : "Inactivated Influenza surface antigen sub-unit vaccine prefilled syringe (product)"
          },
          {
            "code" : "391668002",
            "display" : "Inactivated Influenza vaccine (split virion) prefilled syringe 0.5mL (product)"
          },
          {
            "code" : "391669005",
            "display" : "Inactivated Influenza vaccine (surface antigen) prefilled syringe 0.5mL (product)"
          },
          {
            "code" : "400564003",
            "display" : "Influenza virus vaccine trivalent 45mcg/0.5mL injection solution 5mL vial (product)"
          },
          {
            "code" : "400788004",
            "display" : "Influenza virus vaccine triv 45mcg/0.5mL injection solution 0.5mL syringe (product)"
          },
          {
            "code" : "408752008",
            "display" : "Inactivated influenza split virion vaccine (product)"
          },
          {
            "code" : "414001002",
            "display" : "Administration of vaccine product containing only five component acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and inactivated whole Human poliovirus antigens (procedure)"
          },
          {
            "code" : "414259000",
            "display" : "Administration of first dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type B and inactivated whole Human poliovirus antigens (procedure)"
          },
          {
            "code" : "415507003",
            "display" : "Administration of second dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type B and inactivated whole Human poliovirus antigens (procedure)"
          },
          {
            "code" : "415712004",
            "display" : "Administration of third dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type B and inactivated whole Human poliovirus antigens (procedure)"
          },
          {
            "code" : "418707004",
            "display" : "Inactivated Influenza surface antigen virosome vaccine prefilled syringe (product)"
          },
          {
            "code" : "419562000",
            "display" : "Inactivated Influenza surface antigen virosome vaccine (product)"
          },
          {
            "code" : "429914001",
            "display" : "Inactivated influenza split virus trivalent vaccine 0.5mL vial (product)"
          },
          {
            "code" : "430410002",
            "display" : "Product containing Influenza virus vaccine in nasal dose form (medicinal product form)"
          },
          {
            "code" : "430482001",
            "display" : "Inactivated influenza split virus trivalent vaccine 0.25mL prefilled syringe (product)"
          },
          {
            "code" : "430620004",
            "display" : "Inactivated influenza split virus trivalent vaccine 0.5mL prefilled syringe (product)"
          },
          {
            "code" : "46233009",
            "display" : "Influenza virus vaccine (product)"
          },
          {
            "code" : "770608009",
            "display" : "Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Hepatitis B virus antigens (procedure)"
          },
          {
            "code" : "770616000",
            "display" : "Administration of first dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Hepatitis B virus antigens (procedure)"
          },
          {
            "code" : "770617009",
            "display" : "Administration of second dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Hepatitis B virus antigens (procedure)"
          },
          {
            "code" : "770618004",
            "display" : "Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Hepatitis B virus antigens (procedure)"
          },
          {
            "code" : "786846001",
            "display" : "Administration of vaccine product containing only Haemophilus influenzae type B and Hepatitis B virus antigens (procedure)"
          },
          {
            "code" : "786847005",
            "display" : "Administration of vaccine product containing only Influenza A virus subtype H5N1 antigen (procedure)"
          },
          {
            "code" : "787016008",
            "display" : "Administration of vaccine product containing only Influenza virus antigen in nasal dose form (procedure)"
          },
          {
            "code" : "787436003",
            "display" : "Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B antigens (procedure)"
          },
          {
            "code" : "787438002",
            "display" : "Vaccination for diphtheria, pertussis, tetanus, poliomyelitis, Hepatitis B virus and Haemophilus influenzae type b (procedure)"
          },
          {
            "code" : "86198006",
            "display" : "Administration of vaccine product containing only Influenza virus antigen (procedure)"
          }
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:68d37f15-88da-44a1-8b17-1565dd33de9d",
    "timestamp" : "2024-06-14T14:43:08-04:00",
    "total" : 24,
    "contains" : [
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "127787002",
        "display" : "Administration of vaccine product containing only Haemophilus influenzae type b antigen (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "16292241000119109",
        "display" : "Administration of booster dose of vaccine product containing only Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Clostridium tetani toxoid protein (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "170343007",
        "display" : "Administration of first dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "170344001",
        "display" : "Administration of second dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "170345000",
        "display" : "Administration of third dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "170346004",
        "display" : "Administration of booster dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "310306005",
        "display" : "Administration of first dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "310307001",
        "display" : "Administration of second dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "310308006",
        "display" : "Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "312869001",
        "display" : "Administration of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "312870000",
        "display" : "Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "414001002",
        "display" : "Administration of vaccine product containing only five component acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "414259000",
        "display" : "Administration of first dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "415507003",
        "display" : "Administration of second dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "415712004",
        "display" : "Administration of third dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "770608009",
        "display" : "Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "770616000",
        "display" : "Administration of first dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "770617009",
        "display" : "Administration of second dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "770618004",
        "display" : "Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "786846001",
        "display" : "Administration of vaccine product containing only Haemophilus influenzae type b and Hepatitis B virus antigens (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "786847005",
        "display" : "Administration of vaccine product containing only Influenza A virus subtype H5N1 antigen (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "787016008",
        "display" : "Administration of vaccine product containing only Influenza virus antigen in nasal dose form (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "787436003",
        "display" : "Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b antigens (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "86198006",
        "display" : "Administration of vaccine product containing only Influenza virus antigen (procedure)"
      }
    ]
  }
}
